| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Yocca Frank is a Chief Scientific Officer at BioXcel Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $18K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 430 | $0.35 | $151.82 | -0.7% | -64.9% | -71.1% | |
| Oct 3, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sell | 7,175 | $0.55 | $3,946.25 | -20.2% | -28.7% | -71.3% | |
| Sep 16, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 355 | $0.69 | $244.70 | -2.4% | -36.5% | -70.8% | |
| Jun 17, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 372 | $1.28 | $476.16 | -2.7% | -51.9% | -92.3% | |
| Apr 4, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,067 | $2.64 | $2,811.54 | -7.7% | -59.9% | -96.2% | |
| Mar 15, 2023 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 985 | $19.69 | $19,395.73 | -9.4% | +2.8% | -85.4% | |
| Jan 20, 2023 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sell | 50,000 | $30.00 | $1,500,000.00 | -85.6% | -30.2% | -91.5% | |
| Mar 15, 2021 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sell | 15,000 | $48.50 | $727,572.90 | -11.3% | -21.2% | -69.1% | |
| Feb 16, 2021 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sell | 15,000 | $57.68 | $865,153.12 | -2.7% | - | - | |
| Jan 25, 2021 | BTAI Bioxcel Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 15,000 | $48.39 | $725,814.28 | -3.8% | - | - |